Table 3.

Trial landscape on preventive therapy for DR-TB contacts.

Study	Status	Population Type	Structure	Duration of Treatment	Country	Total Population Size (N)	Duration of Follow-Up
V-QUIN	Enrolment completed	Adults > 15 years	Lfx vs. Placebo	6 months	Vietnam	3344	30 months
TB-CHAMP	Enrolment ongoing	Children < 5 years	Lfx vs. Placebo	6 months	South Africa	1556	24 weeks
PHOENIx	Enrolment ongoing	Adults > 15 years	Dlm vs. H	6 months	International	5610	26 weeks

Abbreviations: Lfx, levofloxacin; Dlm, delamanid and H, isoniazid.